Target Tumors
Target Tumors offers expert advice about targeted therapies for tumors of the brain, stomach, prostate and lung. Medications that that can target cancer cells without harming the rest of the body have become an important part of oncology's cutting edge. They've been around for several years, but recent advances are generating excitement among patients and doctors alike. Join us as we explore the latest developments in tumor treatments.
GI Stromal Tumor (GIST)
Prostate Cancer
Small Cell Lung Cancer
Gliomas
(Spinal Cord or Brain Tumors)
Home

 

Gi Stromal Tumors (GIST)

The Versatility of Gleevec: An Option for More Cancer Patients
Two years ago, when US Food and Drug Administration approved GleevecTM (imatinib mesylate) for the treatment of chronic myeloid leukemia (CML), an uncommon but life-threatening blood cancer, the drug was hailed as a breakthrough. Unlike many other drugs celebrated as breakthroughs, Gleevec has largely fulfilled its promise.
Read Article

 
About Us ResourcesFaculty
Privacy PolicyDisclaimerEditorial & Sponsorship Policy